NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 DrugsZacks Investment Research • 10/17/25
Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive.Investors Business Daily • 10/17/25
Novo Nordisk, Eli Lilly shares drop as Trump promises lower weight loss drug pricesProactive Investors • 10/17/25
Eli Lilly, Novo Nordisk Stocks Drop After Trump's Ozempic Price Comment. What to Know.Barrons • 10/17/25
NVO, OMER Ink $2.1B Zaltenibart Deal to Bolster Rare Disease PortfolioZacks Investment Research • 10/16/25
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease pushReuters • 10/15/25
Novo Nordisk halts work on cell therapy for diabetes to cut costs, Bloomberg News reportsReuters • 10/10/25
Can Novo Nordisk's Aggressive Deal-Making Offset Semaglutide Reliance?Zacks Investment Research • 10/10/25